Non-CME Satellite Symposia

Search by day:

SATURDAY, October 9

SUNDAY, October 10

MONDAY, October 11

SATURDAY, October 19

Managing Intraoperative Hypotension with Predictive Parameters | SAT01
Noon – 1 p.m.
Upper 6C
Edwards Lifesciences, Industry Supporter

Intraoperative hypotension (IOH) is common, harmful, and potentially avoidable. This session will explore the application of Acumen Hypotension Prediction Index (HPI) software to help you manage hypotension. The Acumen HPI software can utilize arterial waveforms from either noninvasive finger cuffs or radial arterial lines to detect the likelihood of a patient trending towards hypotension and provide insight to better understand the root cause(s) of instability.

Speakers:
Ashish K. Khanna, MD, FCCP, FCCM, FASA
Simon Davies MB, ChB, FRCA, MD

The Need for Longer-Acting Local Anesthetics for Postoperative Pain Management | SAT02
Noon – 1 p.m.
Upper 6D-6E
Heron Therapeutics, Industry Supporter

Pain management in the first 72 hours after surgery is critical. As the body’s inflammatory process unfolds, the surgical site becomes increasingly acidic and limits the efficacy of local anesthetics, regardless of administration technique. But what if local anesthetics were capable of more? By attending this symposium, you will learn about how a new local anesthetic designed to consistently deliver pain relief for up to 72 hours after surgery could impact the way we treat pain.

Speaker:
Charles B. Luke, MD, MBA, FASAM

Driving Improved Perioperative Patient Outcomes with Advanced Noninvasive Monitoring | SAT03
Noon – 1 p.m.
Upper 6F
Masimo, Industry Supporter

Advanced noninvasive monitoring systems can enhance clinical decision-making, leading to improved patient outcomes. The flexible integration of continuous, real-time monitoring in the perioperative space can provide anesthesiologists with additional insight into a patient’s condition. New patient management solutions can also help clinicians care for patients remotely in and outside hospital settings.

Speakers:
Bala Subramaniam, MD, MPH, FASA
William C. Wilson, MD, MA
Michael A.E. Ramsay, MD, FRCA
Steven Barker, MD

Sonics & Science in PBM - Optimizing the Management of Critical Coagulopathic Bleeding: Advancements in POC Technology Facilitates a Collaborative Team Approach. | SAT05
5:30 p.m.
Omni Hotel, Ballroom C
HemoSonics, Annual Meeting Supporter

This dinner symposium will address and discuss various real-world operational and communication challenges related to perioperative hemostasis management. This will take into account the various perspectives of those who must work together to effect best possible care of the bleeding or at-risk patient. The educational component will cover first-hand experiences from clinician. As Dinner wraps ups, a hands-on workshop will provide a hands-on educational experience.

The educational dinner will be presented in a fun, light and entertaining atmosphere that will be welcomed as informative and highly relevant to the role of the anesthesiologist in cardiac surgery while at the same time, be a relaxing, enjoyable and social evening event.

Speaker:
Bruce Spiess, MD, FAHA

SuperNO2VA™ Et: Monitor EtCO2 while reducing respiratory complications | SAT06
5:30 p.m.
Omni Hotel, Ballroom DE
Vyaire Medical, Annual Meeting Supporter

The speaker will discuss how maintaining upper airway patency, reducing incidence of upper airway obstruction, and monitoring EtCO2 with SuperNO2VA™ Et provides airway confidence.

Speaker:
Speaker:
Amy K Marino, MD

 

SUNDAY, October 10

Pandemic Patient Blood Management Challenges and Responses – New Perspectives| SAT13
7 – 8 a.m.
Omni Hotel, Salons DE 
Octapharma USA, Inc, Annual Meeting Supporter

As the COVID-19 cases continue to escalate globally, it is imperative to optimize patient outcomes in this catastrophic medical crisis. Perioperative bleeding management in adult and pediatric patients could be very challenging, especially with blood supply shortages during the pandemic. The use of coagulation factor concentrates, such as fibrinogen concentrate, plays an essential role in point-of-care guided bleeding management offering a more targeted approach to optimize hemostatic therapy. Restoring functional fibrinogen levels has been suggested as a key measure to achieve hemostasis and is recommended in the current clinical practice guidelines.

This symposium will address how to apply established principles of patient blood management during the COVID-19 pandemic. Global perspectives of perioperative bleeding management with respect to coagulation factor replacement will be presented. Point-of-care guided management of bleeding with fibrinogen concentrate and prothrombin complex concentrate in adults and pediatrics will be discussed. In addition, the efficacy and safety of fibrinogen concentrates to treat acquired hypofibrinogenemia in surgical settings (e.g., cardiac surgery, liver transplantation) will be reviewed. Different perspectives from the U.S. and Europe on novel approaches to bleeding management amidst a pandemic will be presented.

Speakers:
Melissa Cushing, MD 
Thorsten Haas, MD
Kenichi Tanaka, MD

Understanding the real cost of perioperative patient safety | SAT07
Noon – 1 p.m.
Upper 6C 
Medtronic, Industry Supporter

Deaths within the 30 days after non-cardiac surgery are amongst the most common reasons for mortality in the United States. This is in sharp contrast to intra-operative mortality, which is next to negligible. Code blue events and related adverse clinical deterioration on hospital general care floors or hospital wards are responsible for most of this mortality. The PRODIGY trial published in 2020 conclusively demonstrated the extent of this problem and the value of continuous, portable monitoring in its prevention.  However, there is a cost associated with the implementation and sustainability of a successful continuous monitoring system. Is the cost of adverse episodes that go undetected in the absence of continuous monitoring more than this implementation cost? What is the investment break event point for the investment into continuous monitoring systems? These are some of the areas where this presentation will take an in-depth look at patient safety and a novel cost effectiveness analysis to understand health care economics for improvement of patient monitoring.

Speaker:
Ashish K. Khanna MD, FCCP, FCCM, FASA

Overcoming the Challenges of Postoperative Nausea and Vomiting in the PACU | SAT08
Noon – 1 p.m.
Upper 6D-6E
Acacia Pharma, Industry Supporter

Please join Acacia Pharma for an educational program to discuss clinician needs and current options for the management of postoperative nausea and vomiting (PONV). In this program, you can learn about the burden and consequences of untreated PONV; explore options for treating PONV after failed prophylaxis; and gain knowledge of the safety and efficacy of an FDA-approved antiemetic for rescue treatment of PONV after failed prophylaxis.

Wasted Opportunity: Engaging Anesthesiologists in Optimizing the Use of Controlled Substance
Intravenous Push Products| SAT09
Noon – 1 p.m.
Upper 6F
Fresenius Kabi, Industry Supporter 

Health systems, especially procedural areas, ambulatory surgical centers and operating rooms, lack an awareness of the extent of intravenous push waste, potential for drug diversion, and holistic costs of waste to the health system.  As a result, health systems incur significant costs and risks to ensure proper disposal, management, and regulatory compliance with controlled substances. Drugs with high abuse potential, such as fentanyl, hydromorphone, and morphine are often administered via the intravenous push route, but may not be used in a manner that optimizes clinical, financial and workforce outcomes. A recent continuous observation workflow time study conservatively estimated total combined product and workforce waste per year for a subsect of patient care areas.  Anesthesiologists are uniquely positioned to lead efforts to reduce unnecessary drug waste, adhere to best practices, and limit drug diversion opportunity.

Speakers: 
Jeffrey Vender, MD
John Hertig, PharmD, MS, CPPS, FASHP
Ryan Haumschild, PharmD, MS, MBA

 

MONDAY, October 11

Perioperative Pediatric Anesthesia | SAT04
7 – 8 a.m.
Omni Hotel, Salons DE
Getinge, Annual Meeting Supporter 

In pediatric anesthesia, small adjustments in mechanical ventilation may lead to large physiological changes. The accuracy of measured values becomes critically important as the size of the patient decreases, and the severity of illness increases. Please join us for an educational session in the field of pediatric anesthesiology

Speaker:
Dr. Mark Twite, MA, MB, BChir, FRCP

Physician-Led Advancements in Anesthesia Documentation and Quality Reporting | SAT11
Noon – 1 p.m.
Upper 6C
Provation Medical, Industry Supporter

Technology should work for us, not the other way around.  

During this speaking engagement, practicing anesthesiologist and chief medical officer of iProcedures (now part of Provation), Mani Vindhya, MD, FASA, will candidly discuss the everyday clinician’s “wish list” for electronic documentation and how merging technologies and the latest advancements in automation can address these wants and needs.   

Sponsored by Provation, the new home of top-rated anesthesia vendors iProcedures and ePreop. 

Speaker:
Mani Vindhya, MD, FASA

Driving Innovation and Quality During and After a Pandemic | SAT12
Noon – 1 p.m.
Upper 6D-6E
CAE Healthcare, Industry Supporter

The past year has been transformative. Before 2020, few people considered the impact a pandemic might have on quality, business-prediction models or educational development and distribution. The most difficult challenge for many organizations was innovating quickly enough to stay ahead of the market while still meeting high standards for quality. In this session, a panel of healthcare-simulation and training experts will share the journey of innovation and quality. before, during, and after the pandemic. What did innovation and quality in the healthcare space look like? How did that change? And what does the future hold for those innovation centers trying to grow? Join us for lunch and engage in discussion at the interface of technology, innovation and quality.

Speakers:
Stefan Monk, MD
Christine Park, MD, FASA, FSSH 
Amar Patel, DHSc, MS, NRP, CHSE, FSSH

Neuromuscular Blockade Management in Today’s Clinical Practice | SAT10
Noon – 1 p.m.
Upper 6F
Merck Pharmaceuticals, Industry Supporter  

  • Highlight the current data on the incidence of residual neuromuscular blockade
  • Discuss the management of clinically relevant recovery from neuromuscular block
  • Review clinical data for an option for neuromuscular blockade management

Speaker:
Adam Blomberg, MD